Disc Dynamics gets FDA OK for spinal nucleus replacement trial:
This article was originally published in Clinica
US firm Disc Dynamics stepped up the race for US approval of a spinal nucleus replacement device for treating back pain in degenerative disc disease (DDD), after this month receiving FDA approval to commence a clinical study of its Dascor Disc Arthroscopy System. Rival company Raymedica received FDA approval to commence clinical trials only last month. Other competitors include Replication Medical, Spine Wave, Cryolife, Disc Anugmentation Technologies and Corin. The Dascor Disc Arthroscopy System has been CE-marked for sale in Europe since 2003 said the Eden Prairie, Minnesota-based firm. Spinal nucleus replacement provides a minimally invasive alternative to spinal fusion and total disc replacement for treating DDD.